[Antibiotic allergies: targeted approach in suspected β‑lactam allergy]

Area of Science:

• Pharmacology
• Immunology
• Clinical Medicine

Context:

• Hypersensitivity drug reactions encompass antibiotic allergies, manifesting as IgE-mediated or T-cell-mediated symptoms, commonly skin reactions.
• A penicillin allergy diagnosis often leads to restricted treatment options for infections, potentially worsening outcomes.
• However, the 'penicillin allergy' label is frequently unverified, despite its significant clinical implications.

Purpose:

• To differentiate true penicillin allergy from non-specific intolerance reactions.
• To highlight the importance of accurate diagnosis for optimizing antibiotic treatment strategies.
• To inform clinical practice regarding penicillin de-labeling and cross-reactivity assessment.

Summary:

• 85-90% of patients labeled with penicillin allergy actually have non-specific intolerance, posing no risk upon re-exposure.
• Detailed patient history and simple diagnostic steps are key to distinguishing true allergy from intolerance.
• A penicillin de-labeling approach facilitates better antibiotic choices for future infections.

Impact:

• Accurate penicillin allergy assessment enables optimized antibiotic selection, improving patient care.
• Reducing mislabeling of penicillin allergy can prevent unnecessary broad-spectrum antibiotic use.
• Understanding cross-reactivity among beta-lactam antibiotics aids in selecting safer alternatives.